Close

Articles Posted in Pharmaceutical Injuries

Updated:

Illinois Appellate Court Rules That a Party’s Failure to Seek a Contribution Action in the Underlying Lawsuit Would Be Barred from Later Filing

The First District Appellate Court affirmed a decision of a Cook County trial court. In 1999, Snake River Technology d/b/a Rocky Mountain Cryobanks, a Wyoming company, was purchased by the New England Cryogenics Center, a Massachusetts corporation that collects, stores and sells human sperm. The purchase included the sperm donor…

Updated:

U.S. Court of Appeals Affirms Dismissal of Pharmaceutical Defect Lawsuit as Plaintiff’s Expert Witness is Excluded

The United States Court of Appeals for the Seventh Circuit in Chicago has affirmed the grant of defendant’s motion for summary judgment in the plaintiff’s lawsuit that alleged that the product Testim, which was manufactured by Auxilium Pharmaceuticals as a topical gel containing testosterone, caused the plaintiff, Isaac Owens, to…

Updated:

$2.6 Million Jury Verdict for Woman Injured by IVC Blood Filters

Sherr-Una Booker, 37, was implanted with a Bard G2 blood filter on June 21, 2007. The blood filter was intended to prevent blood clots. It broke apart, spreading metal fragments that had to be removed from her heart. She required open-heart surgery. These inferior vena cava (IVC) filters — like…

Updated:

$35 Million Jury Verdict for Woman Injured by Vaginal Mesh Implant

An Indiana federal jury returned a $35 million verdict in favor of Barbara Kaiser who alleged she was injured by a vaginal mesh implant. The jury’s verdict found that defendants Johnson & Johnson and Ethicon Inc. were negligent in the design of the trans-vaginal mesh and then chose not to…

Updated:

U.S. District Court Rules That Attorney-Client Privilege Applied in Insurance Coverage Lawsuit

Baxter International was sued in a second wave of multidistrict litigation filed by hemophiliacs who alleged that they contracted HIV or Hepatitis C from contaminated blood products. Baxter paid $15 million to settle the lawsuits and then filed its own lawsuit against Axa Versicherung and a German insurance company for…

Updated:

$9 Billion Actos Damage Award Against Takeda and Lilly is Upheld

A U.S. district court judge has rejected the attempts of Takeda Pharmaceutical Co. and Eli Lilly & Co. to overturn the combined $9 billion punitive-damage award that a jury recently returned. The verdict came down in a case that involved claims that the drug makers chose to hide the cancer…

Updated:

Writ of Mandamus is Denied by Seventh Circuit Court of Appeals in Paxil Case

The Paxil drug maker, GlaxoSmithKline, LLC (GSK) is defending product-liability lawsuits in Chicago’s federal district court for the Northern District of Illinois. GSK manufactures the antidepressant Paxil, which is the brand-name of paroxetine hydrochloride. In one of the many lawsuits that are pending, a 2010 suicide took place just six…

Updated:

Risperdal Whistleblowers Will Receive $168 Million Related to the Johnson & Johnson Department of Justice Settlement

The U.S. Justice Department reached a settlement with Johnson & Johnson, which is the maker of Risperdal. The settlement of $2.2 billion and a misdemeanor plea comes after a long investigation into the marketing of the pharmaceutical product, Risperdal. It is an anti-psychotic drug known to deliver harmful side effects,…

Updated:

$28 Million Settlement Reached with Merck for Fosamax Jaw-Injury Claims

A settlement agreement that includes claims of more than 1,200 plaintiffs in federal and state courts has been reached with Merck & Co. Inc. to pay $27.7 million related to the bone drug Fosamax. Fosamax has been claimed to have caused a condition known as osteonecrosis of the jaw. Osteonecrosis is a…

Updated:

U.S. District Court Orders $1 Million as Sanctions in Discovery Abuses in Predaxa Drug Lawsuits

Federal District Court Judge Hon. David R. Herndon of the Southern District of Illinois has ordered that Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) pay $1 million in sanctions for discovery abuses in the multidistrict litigation (MDL) involving the oral anticoagulant Predaxa. This same U.S. Federal District Court, also in the Southern District…

Contact Us